DexCom, Inc. (DXCM) Q4 2021 Earnings Results

Dexcom Misses on EPS, Stock Down 1.25%

Dexcom's earnings report indicates a disappointing quarter with a notable EPS miss, leading to a 1.25% decline in stock price. The lack of revenue data and guidance suggests uncertainty in the company's near-term performance. Investors may be cautious as management highlights ongoing market challenges.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.68	N/A	-20.65%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about market conditions impacting performance. They remain focused on strategic initiatives for future growth.

Management noted challenges in the current market environment.

They emphasized a focus on long-term growth despite short-term hurdles.

Dexcom Misses on EPS, Stock Down 1.25%

Key numbers

Management commentary

DexCom, Inc.

More earnings this week

Dexcom Misses on EPS, Stock Down 1.25%

Key numbers

Management commentary